Listing Of MNC Arms In India Has Been Rough Ride With Stray Sparks Of Hope

MUMBAI - As Pfizer Inc. looks to potentially spin-off its emerging markets unit and analysts talk openly about spin-outs for other companies as well, industry watchers may want to take a closer look at India, where several Big Pharma have had separately listed subsidiaries for decades

More from Archive

More from Scrip